UniProt ID | LST8_HUMAN | |
---|---|---|
UniProt AC | Q9BVC4 | |
Protein Name | Target of rapamycin complex subunit LST8 | |
Gene Name | MLST8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 326 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Subunit of both mTORC1 and mTORC2, which regulates cell growth and survival in response to nutrient and hormonal signals. mTORC1 is activated in response to growth factors or amino acids. Growth factor-stimulated mTORC1 activation involves a AKT1-mediated phosphorylation of TSC1-TSC2, which leads to the activation of the RHEB GTPase that potently activates the protein kinase activity of mTORC1. Amino acid-signaling to mTORC1 requires its relocalization to the lysosomes mediated by the Ragulator complex and the Rag GTPases. Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. mTORC1 phosphorylates EIF4EBP1 and releases it from inhibiting the elongation initiation factor 4E (eiF4E). mTORC1 phosphorylates and activates S6K1 at 'Thr-389', which then promotes protein synthesis by phosphorylating PDCD4 and targeting it for degradation. Within mTORC1, LST8 interacts directly with MTOR and enhances its kinase activity. In nutrient-poor conditions, stabilizes the MTOR-RPTOR interaction and favors RPTOR-mediated inhibition of MTOR activity. mTORC2 is also activated by growth factors, but seems to be nutrient-insensitive. mTORC2 seems to function upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors. mTORC2 promotes the serum-induced formation of stress-fibers or F-actin. mTORC2 plays a critical role in AKT1 'Ser-473' phosphorylation, which may facilitate the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDK1 which is a prerequisite for full activation. mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422'. mTORC2 also modulates the phosphorylation of PRKCA on 'Ser-657'.. | |
Protein Sequence | MNTSPGTVGSDPVILATAGYDHTVRFWQAHSGICTRTVQHQDSQVNALEVTPDRSMIAAAGYQHIRMYDLNSNNPNPIISYDGVNKNIASVGFHEDGRWMYTGGEDCTARIWDLRSRNLQCQRIFQVNAPINCVCLHPNQAELIVGDQSGAIHIWDLKTDHNEQLIPEPEVSITSAHIDPDASYMAAVNSTGNCYVWNLTGGIGDEVTQLIPKTKIPAHTRYALQCRFSPDSTLLATCSADQTCKIWRTSNFSLMTELSIKSGNPGESSRGWMWGCAFSGDSQYIVTASSDNLARLWCVETGEIKREYGGHQKAVVCLAFNDSVLG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 (in isoform 4) | Acetylation | - | 12.77 | 19369195 | |
1 | Acetylation | -------MNTSPGTV -------CCCCCCCC | 12.77 | 19369195 | |
3 | Phosphorylation | -----MNTSPGTVGS -----CCCCCCCCCC | 34.69 | 25159151 | |
4 | Phosphorylation | ----MNTSPGTVGSD ----CCCCCCCCCCC | 19.14 | 25159151 | |
7 | Phosphorylation | -MNTSPGTVGSDPVI -CCCCCCCCCCCCEE | 25.69 | 30108239 | |
7 (in isoform 4) | Phosphorylation | - | 25.69 | 17192257 | |
10 | Phosphorylation | TSPGTVGSDPVILAT CCCCCCCCCCEEEEE | 34.11 | 30108239 | |
12 (in isoform 4) | Phosphorylation | - | 19.42 | 24247654 | |
17 | Phosphorylation | SDPVILATAGYDHTV CCCEEEEECCCCCHH | 19.71 | 26074081 | |
19 (in isoform 4) | Phosphorylation | - | 24.85 | 18691976 | |
20 | Phosphorylation | VILATAGYDHTVRFW EEEEECCCCCHHEEH | 11.33 | 26074081 | |
20 (in isoform 3) | Ubiquitination | - | 11.33 | 21906983 | |
23 | Phosphorylation | ATAGYDHTVRFWQAH EECCCCCHHEEHHHC | 15.52 | 24425749 | |
37 | Phosphorylation | HSGICTRTVQHQDSQ CCCCCEEEEECCCCC | 13.33 | 20873877 | |
43 | Phosphorylation | RTVQHQDSQVNALEV EEEECCCCCCCEEEE | 29.47 | 20873877 | |
51 | Phosphorylation | QVNALEVTPDRSMIA CCCEEEECCCHHHHH | 15.31 | 26091039 | |
55 | Phosphorylation | LEVTPDRSMIAAAGY EEECCCHHHHHHHCC | 23.17 | - | |
62 | Phosphorylation | SMIAAAGYQHIRMYD HHHHHHCCCEEEEEE | 7.68 | 29496907 | |
85 | Ubiquitination | IISYDGVNKNIASVG CEEECCCCCCEEEEE | 36.87 | 21963094 | |
86 (in isoform 1) | Ubiquitination | - | 47.53 | 21906983 | |
86 | Ubiquitination | ISYDGVNKNIASVGF EEECCCCCCEEEEEE | 47.53 | 2190698 | |
92 | Ubiquitination | NKNIASVGFHEDGRW CCCEEEEEEEECCCE | 18.72 | 21963094 | |
101 | Phosphorylation | HEDGRWMYTGGEDCT EECCCEEEECCCCCC | 8.69 | 29496907 | |
105 (in isoform 4) | Ubiquitination | - | 51.78 | 21906983 | |
111 | Ubiquitination | GEDCTARIWDLRSRN CCCCCEEHHHHHHCC | 2.88 | 21963094 | |
141 | Ubiquitination | VCLHPNQAELIVGDQ EEECCCCEEEEEECC | 21.87 | 21963094 | |
149 | Ubiquitination | ELIVGDQSGAIHIWD EEEEECCCCCEEEEE | 34.63 | 21963094 | |
157 | Ubiquitination | GAIHIWDLKTDHNEQ CCEEEEECCCCCCCC | 3.75 | 21963094 | |
163 | Ubiquitination | DLKTDHNEQLIPEPE ECCCCCCCCCCCCCC | 43.26 | 21963094 | |
179 | Ubiquitination | SITSAHIDPDASYMA EEEEEEECCCCCCEE | 25.76 | 21963094 | |
195 | Ubiquitination | VNSTGNCYVWNLTGG EECCCCEEEEECCCC | 16.70 | 21963094 | |
201 | Ubiquitination | CYVWNLTGGIGDEVT EEEEECCCCCCHHHH | 28.96 | 21963094 | |
214 | Phosphorylation | VTQLIPKTKIPAHTR HHHCCCCCCCCCCCE | 28.93 | 20068231 | |
214 | Ubiquitination | VTQLIPKTKIPAHTR HHHCCCCCCCCCCCE | 28.93 | 21963094 | |
215 | Ubiquitination | TQLIPKTKIPAHTRY HHCCCCCCCCCCCEE | 53.47 | 21963094 | |
221 | Ubiquitination | TKIPAHTRYALQCRF CCCCCCCEEEEEEEC | 12.59 | 21963094 | |
222 | Phosphorylation | KIPAHTRYALQCRFS CCCCCCEEEEEEECC | 16.90 | - | |
239 | Ubiquitination | STLLATCSADQTCKI CEEEEECCCCCCCEE | 30.44 | 21963094 | |
240 | Ubiquitination | TLLATCSADQTCKIW EEEEECCCCCCCEEE | 18.31 | 21963094 | |
244 | Ubiquitination | TCSADQTCKIWRTSN ECCCCCCCEEEEECC | 2.21 | 21963094 | |
245 | Ubiquitination | CSADQTCKIWRTSNF CCCCCCCEEEEECCC | 49.00 | 21963094 | |
249 | Phosphorylation | QTCKIWRTSNFSLMT CCCEEEEECCCEEEE | 17.02 | 28509920 | |
250 | Phosphorylation | TCKIWRTSNFSLMTE CCEEEEECCCEEEEE | 27.57 | 28509920 | |
251 | Ubiquitination | CKIWRTSNFSLMTEL CEEEEECCCEEEEEE | 29.88 | 21963094 | |
259 | Phosphorylation | FSLMTELSIKSGNPG CEEEEEEEECCCCCC | 23.03 | 29083192 | |
260 | Ubiquitination | SLMTELSIKSGNPGE EEEEEEEECCCCCCC | 6.86 | 21963094 | |
261 | Ubiquitination | LMTELSIKSGNPGES EEEEEEECCCCCCCC | 49.27 | 21963094 | |
267 | Ubiquitination | IKSGNPGESSRGWMW ECCCCCCCCCCCEEE | 46.96 | 21963094 | |
270 | Ubiquitination | GNPGESSRGWMWGCA CCCCCCCCCEEEEEE | 52.66 | 21963094 | |
286 | Ubiquitination | SGDSQYIVTASSDNL CCCCCEEEEECCCCE | 2.89 | 21963094 | |
304 | Ubiquitination | WCVETGEIKREYGGH EEEECCCEEHHHCCC | 5.58 | 21963094 | |
305 | Ubiquitination | CVETGEIKREYGGHQ EEECCCEEHHHCCCC | 34.57 | 21963094 | |
305 | Sumoylation | CVETGEIKREYGGHQ EEECCCEEHHHCCCC | 34.57 | - | |
311 | Ubiquitination | IKREYGGHQKAVVCL EEHHHCCCCCEEEEE | 22.93 | 21963094 | |
330 | Ubiquitination | SVLG----------- CCCC----------- | 21963094 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LST8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LST8_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3; SER-4 AND THR-7,PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7 (ISOFORM 3), AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4, PHOSPHORYLATION[LARGE SCALE ANALYSIS] AT SER-7 (ISOFORM 3), AND MASS SPECTROMETRY. |